From the full post on paulsufka.com:

I’m thrilled to announce that the online rheumatology community has been asked to join the next #NephJC, which will be held Tuesday, December 16 from 9-10 PM EST / 8-9 PM CST.

We’ll be discussing the recent NEJM article Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis (PMID: 25372085)

For my rheumatology colleagues that are not familiar, #NephJC is a thriving nephrology journal club on Twitter and NephJC.com. If you’re relatively new to Twitter and using hashtags, but would like to participate, the simplest way would be to follow the instructions on their site.

I’m excited to see what we’re able to learn from our nephrology colleagues, and hope us rheumatologists have much to share as well.

See the full post for background on the use of rituximab for ANCA-associated vasculitis and summary of the NEJM article.